Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis.
about
Evaluation of First-Line Sorafenib Treatment for Metastatic Renal Cell Carcinoma in Kidney Transplant Patients: A Single-Center Experience With Four Cases.Differences in Clinical and Pathological Features of Renal Cell Carcinoma Between Japanese Patients After Kidney Transplantation and Those on Hemodialysis.Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four cases.
P2860
Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Efficacy and safety of sorafen ...... ients undergoing hemodialysis.
@ast
Efficacy and safety of sorafen ...... ients undergoing hemodialysis.
@en
type
label
Efficacy and safety of sorafen ...... ients undergoing hemodialysis.
@ast
Efficacy and safety of sorafen ...... ients undergoing hemodialysis.
@en
prefLabel
Efficacy and safety of sorafen ...... ients undergoing hemodialysis.
@ast
Efficacy and safety of sorafen ...... ients undergoing hemodialysis.
@en
P2093
P2860
P1476
Efficacy and safety of sorafen ...... tients undergoing hemodialysis
@en
P2093
Hirohito Kobayashi
Junpei Iizuka
Kazunari Tanabe
Takafumi Kennoki
Toshio Takagi
Tsunenori Kondo
Yasunobu Hashimoto
P2860
P2888
P304
P356
10.1007/S10147-015-0871-Y
P50
P577
2015-07-11T00:00:00Z